Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

The Effects of Tai Chi in Individuals With Multiple Sclerosis

9 november 2026 uppdaterad av: Büşra ÇATALTAŞ, Pamukkale University

The Effects of Tai Chi on Executive Functions in Individuals With Multiple Sclerosis: A Randomized Controlled Trial

This study aimed to evaluate the effects of Tai Chi exercise on cognitive functions, fatigue, and depressive symptoms in individuals with Multiple Sclerosis (MS). MS is a chronic neurological disease characterized by demyelination within the central nervous system and is frequently associated with cognitive, physical, and psychological impairments.

Individuals diagnosed with MS were assigned to either an 8-week Tai Chi exercise program or a home-based Frenkel exercise program. Cognitive functions were assessed using the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS), which comprises the Symbol Digit Modalities Test (SDMT), California Verbal Learning Test-II (CVLT-II), and Brief Visuospatial Memory Test-Revised (BVMT-R). Fatigue was evaluated using the Fatigue Impact Scale (FIS), while depressive symptoms were assessed using the Beck Depression Inventory (BDI).

The study aimed to investigate the effects of Tai Chi exercise compared with a home-based exercise program on cognitive performance, fatigue, and depressive symptoms in individuals with MS. The findings may contribute to the evidence base for non-pharmacological rehabilitation approaches in MS management.

Studieöversikt

Detaljerad beskrivning

Multiple Sclerosis (MS) is a chronic, immune-mediated neurological disease characterized by inflammation, demyelination, and neurodegeneration within the central nervous system. Cognitive impairment, fatigue, and depression are among the most common and disabling symptoms in individuals with MS, significantly affecting their quality of life. In addition to pharmacological treatments, exercise-based rehabilitation approaches have gained increasing attention in recent years.

This randomized controlled study investigated the effects of a structured Tai Chi exercise program on cognitive functions, fatigue, and depressive symptoms in individuals with MS. Participants diagnosed with MS were randomly allocated to either a Tai Chi intervention group or an active control group receiving a home-based Frenkel exercise program. Both groups continued their standard medical care throughout the study.

The Tai Chi intervention was conducted over 8 weeks, with two supervised sessions per week. Each session lasted approximately 50 minutes and included warm-up exercises, Tai Chi practice, and cool-down activities.

Cognitive functions were assessed using the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS), which comprises three tests: the Symbol Digit Modalities Test (SDMT), assessing information processing speed; the California Verbal Learning Test-II (CVLT-II), assessing verbal learning and memory; and the Brief Visuospatial Memory Test-Revised (BVMT-R), assessing visuospatial learning and memory. Fatigue was evaluated using the Fatigue Impact Scale (FIS), while depressive symptoms were assessed using the Beck Depression Inventory (BDI).

The primary outcome was cognitive performance following the intervention, while secondary outcomes included changes in fatigue and depressive symptoms. All outcome measures were assessed at baseline and after the 8-week intervention period.

This study aimed to contribute to the evidence regarding the potential role of Tai Chi as a non-pharmacological rehabilitation approach for managing cognitive and psychological symptoms in individuals with MS.

Studietyp

Interventionell

Inskrivning (Faktisk)

44

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Denizli
      • Denizli, Denizli, Turkiet (Türkiye), 20000
        • Pamukkale University

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

20 år till 60 år (Vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  1. Diagnosis of multiple sclerosis (MS) according to the McDonald criteria.
  2. Relapsing-remitting multiple sclerosis (RRMS) phenotype.
  3. Age between 20 and 60 years.
  4. Willingness to participate in the study.
  5. Expanded Disability Status Scale (EDSS) score ≤3.5.

Exclusion Criteria:

  1. Use of medications that could affect clinical assessment or cognitive test performance, including antipsychotic medications or continuous corticosteroid or immunosuppressive therapy within the preceding month.
  2. Presence of additional neurological, psychiatric, or systemic diseases that could affect clinical or cognitive assessments.
  3. Participation in another structured exercise program.
  4. Experiencing an MS relapse within the preceding four weeks.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Tai Chi Intervention Group

Participants received an 8-week Tai Chi intervention program designed for individuals with Multiple Sclerosis. The program included coordinated body movements, breathing control, and mindful movement practice, aiming to improve cognitive function, reduce fatigue, and improve depression levels in individuals with MS. The program consisted of progressively taught 8 movements selected from the basic 10 Yang-style forms, focusing on controlled weight shifting, postural alignment, and whole-body coordination. Each session consisted of a warm-up phase with general stretching exercises, a main Tai Chi practice component with form repetition and rest breaks as needed, and a cool-down phase including stretching and controlled breathing exercises.

Tai Chi was administered for 8 weeks, 2 days per week, for a total of 16 sessions. Each session lasted approximately 50 minutes and included warm-up stretching exercises (10 minutes), Tai Chi practice (30 minutes), and cool-down exercises (10 minutes). Sessions were conducted in groups of 2-3 participants under physiotherapist supervision.

Aktiv komparator: Home Exercises Group

Participants in this group received an 8-week home exercise program consisting of Frenkel coordination exercises. They were instructed to perform the prescribed exercises independently at home throughout the study period. Participants did not participate in the Tai Chi intervention. The program served as an active comparator for evaluating the effects of Tai Chi on cognitive function, fatigue, and depression in individuals with MS.

Participants performed a home-based Frenkel exercise program for 8 weeks, twice weekly. Each session lasted approximately 15-30 minutes, excluding rest periods. Participants received an instructional booklet and an exercise logbook to record their exercise sessions. Adherence was monitored through telephone follow-up calls every two weeks.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Cognitive functions assessed using the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)
Tidsram: Baseline and 8 weeks after the intervention

Cognitive functions were assessed using the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS), which includes the Symbol Digit Modalities Test (SDMT), California Verbal Learning Test-II (CVLT-II), and Brief Visuospatial Memory Test-Revised (BVMT-R).

Baseline and 8 weeks after the intervention
Symbol Digit Modalities Test (SDMT)
Tidsram: Baseline and 8 weeks after the intervention.

Information processing speed was assessed using the Symbol Digit Modalities Test (SDMT). Higher scores indicate better cognitive performance

Baseline and 8 weeks after the intervention.
California Verbal Learning Test-II (CVLT-II)
Tidsram: Baseline and 8 weeks after the intervention.

Verbal learning and memory were assessed using the California Verbal Learning Test-II (CVLT-II). Higher scores indicate better verbal learning and memory performance.

Baseline and 8 weeks after the intervention.
Brief Visuospatial Memory Test-Revised (BVMT-R)
Tidsram: Baseline and 8 weeks after the intervention.

Visuospatial learning and memory were assessed using the Brief Visuospatial Memory Test-Revised (BVMT-R). Higher scores indicate better visuospatial learning and memory performance.

Baseline and 8 weeks after the intervention.

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Fatigue Impact Scale (FIS) score
Tidsram: Baseline and 8 weeks after the intervention

The impact of fatigue on physical, cognitive, and social functioning was assessed using the Fatigue Impact Scale (FIS). Lower scores indicate less fatigue-related impact.

Baseline and 8 weeks after the intervention
Beck Depression Inventory (BDI) score
Tidsram: Baseline and 8 weeks after the intervention

Depressive symptoms were assessed using the Beck Depression Inventory (BDI). Lower scores indicate fewer depressive symptoms.

Baseline and 8 weeks after the intervention

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

2 oktober 2023

Primärt slutförande (Faktisk)

28 februari 2025

Avslutad studie (Faktisk)

28 februari 2025

Studieregistreringsdatum

Först inskickad

4 november 2026

Först inskickad som uppfyllde QC-kriterierna

4 november 2026

Första postat (Faktisk)

10 november 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

12 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

9 november 2026

Senast verifierad

1 november 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera